NCT00232037View on ClinicalTrials.gov

Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia

PHASE3CompletedINTERVENTIONAL

Enrollment

359

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

August 31, 2006

Conditions

Dyspepsia

Interventions

DRUG

Tegaserod

Trial Locations (1)

07936-108

Novartis, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY